To ascertain if the enhancer was active in ovarian cancer cells and may be responsible for this increased expression, we downloaded publicly available H3K27ac and BRD4 ChIP-seq datasets and looked for the enrichment of these marks at the CSF1 enhancer region (Figure 5B) [54,55]. Here, BRD4 is linked to ovarian carcinoma.